These findings highlight the notion that inflammation occurs in the early stages of obesity and glucose dysregulation, and inflammation may be a key mechanism responsible for changes in epidermal innervation that subsequently leads to the development of PN in insulin resistant humans. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.